Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Capricor Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| | | Fee | | Proposed | | | | | | |
| | | Calculation | | Maximum | Maximum | | | | | |
| | Security | or Carry | | Offering | Aggregate | | | Amount of | ||
| Security | Class | Forward | Amount | Price Per | Offering | Fee | Registration | |||
| Type | Title | Rule | Registered (1) | Unit | Price | Rate | Fee | |||
| | Common Stock | | | | | | | | | |
Fees to be Paid | Equity | $0.001 par value | Rule 457(c) | 2,798,507 | $19.33 (2) | $ | 54,095,140.31 | $ | 0.0001531 | $ | 8,281.99 |
| | per share | | | | | | | | | |
| Total Offering Amounts | | $ | 54,095,140.31 | | | $ | 8,281.99 | |||
| Total Fees Previously Paid | | | | | | $ | — | |||
| Total Fee Offsets | | | | | | $ | — | |||
| Net Fee Due | | | | | | $ | 8,281.99 | |||
(1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement on Form S-3 (the “Registration Statement”) also covers an indeterminate number of shares of common stock, par value $0.001 per share, of Capricor Therapeutics, Inc. that may be offered or issued as a result of any adjustment to prevent dilution by reason of any stock dividend, stock split, reverse stock split, recapitalization or other similar transaction. |
|
|
(2) | Estimated in accordance with Rule 457(c) under the Securities Act solely for purposes of calculating the registration fee and based on the average of the high and low sale prices per share of common stock as reported on The Nasdaq Capital Market on October 17, 2024, which date is within five business days prior to filing this Registration Statement. |